Revising heart failure guidelines is crucial. Current recommendations need updates on beta-blockade, digoxin, angiotensin II receptor antagonists, and anticoagulants for better patient outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Framework:
Implementation:
Implications: